(Circulation. 1995;91:1996-2001.)
© 1995 American Heart Association, Inc.
Articles |
Ventricular Arrhythmias Detected After Transvenous Defibrillator Implantation in Patients With a Clinical History of Only Ventricular Fibrillation
Implications for Use of Implantable Defibrillator
From the Division of Cardiology, Department of Medicine, University of Washington, Seattle.
Correspondence to Gust H. Bardy, MD, Division of Cardiology RG-22, 1959 NE Pacific, University of Washington, Seattle, WA 98195.
Background Patients with a history of ventricular fibrillation (VF) have been shown to have a clinical profile, response to electrophysiological testing (EPS), and response to antiarrhythmic therapy that distinguishes them from patients with a history of sustained monomorphic ventricular tachycardia (MVT). Despite these differences, it is not clear whether VF in these patients is triggered by MVT or occurs de novo. The incidence of MVT and VF in such patients after their index VF event has important implications for therapeutic decisions regarding implantable defibrillator selection and programming.
Methods and Results The records of 111 consecutive patients who had undergone transvenous cardioverter/defibrillator (ICD) implantation for malignant ventricular arrhythmias were reviewed retrospectively. For each patient, all device tachyarrhythmia detections were examined and classified as VF, MVT, rapid polymorphic VT, or other. The number of events, time to first arrhythmia detection, and cycle length of MVTs were recorded. There were 55 patients with a history of only VF and 56 with a history that included an episode of MVT. Over 14 months of follow-up, with all patients initially off of antiarrhythmic medications, MVT was detected by only 18% of patients with a history of only VF compared with 54% of those with a history that included MVT (P=.002). Among patients who did detect MVT, those with a history of only VF had fewer episodes (7±7 versus 20±31, P=.001) and a shorter mean MVT cycle length (279 versus 314 ms, P=.03) than those with a clinical history of MVT. Abrupt onset of VF not preceded by MVT was detected in 11% of patients with VF only. In addition to a history of MVT, male sex, age <60 years, and MVT inducible on EPS were all significantly associated with an increased likelihood of MVT detection. On multivariate analysis, the inducibility of MVT was the primary independent predictor of MVT detection but was of minimal incremental predictive value in the subgroup of patients with a history of only VF. When EPS results were not considered, arrhythmia history was the primary independent predictor of MVT detection.
Conclusions Patients with a history of only VF infrequently have MVT detected by their defibrillators. When these patients do detect MVT, it is faster than that detected in patients with a clinical history of MVT before ICD surgery. A significant percentage of VF survivors detected the abrupt onset of VF not preceded by MVT, suggesting that the deterioration of rapid MVT to VF is not the only clinically important mechanism of VF induction. These findings may have important implications for the understanding of the mechanism of VF induction and for use of an implantable defibrillator.
Key Words: defibrillation • fibrillation • tachycardia • electrophysiology
This article has been cited by other articles:
 |
|
 |
|
  J. M Morgan PATIENTS WITH VENTRICULAR ARRHYTHMIAS: WHO SHOULD BE REFERRED TO AN ELECTROPHYSIOLOGIST? Heart, December 1, 2002; 88(5): 544 - 550. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Buxton, K. L. Lee, G. E. Hafley, D. G. Wyse, J. D. Fisher, M. H. Lehmann, L. A. Pires, M. R. Gold, D. L. Packer, M. E. Josephson, et al. Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial Circulation, November 5, 2002; 106(19): 2466 - 2472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Wathen, M. O. Sweeney, P. J. DeGroot, A. J. Stark, J. L. Koehler, M. B. Chisner, C. Machado, and W. O. Adkisson Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease Circulation, August 14, 2001; 104(7): 796 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.N.W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P.E. Vardas Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology Eur. Heart J., July 1, 2001; 22(13): 1074 - 1081. [PDF]
|
|
|
|
 |
|
 G. Gronefeld and S. H Hohnloser What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death? Cardiovasc Res, May 1, 2001; 50(2): 232 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Swerdlow Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation Circulation, May 1, 2001; 103(17): 2159 - 2164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P. E. Vardas Indications for implantable cardioverter defibrillator (ICD) therapy: Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology Europace, January 1, 2001; 3(3): 169 - 176. [PDF]
|
|
|
|
 |
|
 D. Bansch, M. Castrucci, D. Bocker, G.u. Breithardt, and M. Block Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance J. Am. Coll. Cardiol., August 1, 2000; 36(2): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Andrews, R. I. Fogel, G. Pelargonio, J. J. Evans, and E. N. Prystowsky Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: A comparison with patients known to have sustained ventricular tachycardia J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2023 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mont, M. Valentino, A. Sambola, M. Matas, L. Aguinaga, and J. Brugada Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation J. Am. Coll. Cardiol., August 1, 1999; 34(2): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ruppel, C. A. Schluter, S. Boczor, T. Meinertz, M. Schluter, K.-H. Kuck, and R. Cappato Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1724 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Swerdlow, C. T. Peter, R. M. Kass, E. S. Gang, W. J. Mandel, C. Hwang, D. J. Martin, and P.-S. Chen Programming of Implantable Cardioverter-Defibrillators on the Basis of the Upper Limit of Vulnerability Circulation, March 18, 1997; 95(6): 1497 - 1504. [Abstract] [Full Text]
|
|